REBETOL (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the REBETOL drug offered from Merck Sharp & Dohme Corp.. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | ribavirin |
| SUBSTANCE NAME: | RIBAVIRIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1998-06-03 |
| END MARKETING DATE: | 0000-00-00 |
REBETOL HUMAN PRESCRIPTION DRUG Details:
| Item Description | REBETOL from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 1998-06-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0085-1194_a9e99485-26c9-4768-abee-f6629dd7092b |
| PRODUCT NDC: | 0085-1194 |
| APPLICATION NUMBER: | NDA020903 |
Other RIBAVIRIN Pharmaceutical Manufacturers / Labelers:
